Generic for Revlimid was listed as the lowest price

By Lee, Tak-Sun | translator Choi HeeYoung

22.02.22 12:07:14

가나다라 0

It is differentiated from other products in the 50,000 won range and 70,000 to 80,000 won range, such as Samyang Holdings

Generic drugs, not enough for the original., pay attention to changes in the market

Boryung Pharmaceutical is launching a generic drug called Revlimid (Renalidomide) for multiple myeloma treatment after four years of approval. With three general companies targeting the market since 2018, Boryung has thrown a winning move at the lowest price.

According to the contents of the "Partial revision of the drug benefit list and upper limit table" released by the MOHW on the 21st, four capacities of Boryung Pharmaceutical's generic for Revlimid will be listed from March 1. It has been about four years since it was first approved in June 2018 with 25 mg.

Generic for Revlimid has been on the market since January 2018. Currently, Chong Kun Dang's Lenaloma, Kwang Dong Pharmaceutical'

Lee, Tak-Sun(hooggasi2@dailypharm.com)

If you want to see the full article, please JOIN US (click)